Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure
Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.
EMA committee recommends Novo Nordisk’s Wegovy label update to reflect reduced heart failure symptoms and improved physical function
Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST]
European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart failure symptoms, physical limitations, and exercise function in patients with obesity-related HFpEF.
EU regulator backs use of Novo's Wegovy for obesity-related heart condition
The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday. This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the medicine has multiple health benefits.
Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits
Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a
Endovascular therapy improves left ventricular diastolic function in heart failure with preserved ejection fraction
For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...
Heart Failure: Key points on the silent killer everyone must be aware of
Heart failure arises when the heart cannot pump blood efficiently, leading to symptoms such as shortness of breath and ...
FierceBiotech1d
Edgewise's stock jumps 50% on the back of safety data for potential heart disease rival to Camzyos
Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...
Daily6h
Metformin Associated with Lower Mortality Rates in Diabetes Patients With Heart Failure: Study
China: A recent meta-analysis has provided compelling evidence regarding the use of metformin in patients with type 2 ...
7-year-old in hospital fighting for her life after second heart failure
CINCINNATI ( WXIX /Gray News) - A 7-year-old is in a hospital in Ohio fighting for her life after experiencing her second heart failure. Nyla Pritchett has been at Cincinnati Children’s Hospital since ...
Medscape10d
Finerenone Reduces T2D Onset by 25% in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
In addition to improving heart failure symptoms, finerenone reduced the onset of new type 2 diabetes in patients with mildly ...
ahajournals.org10d
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association
Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. In ...
Endocrinology Advisor3d
SGLT2 Inhibitors Cut Kidney Risks Across CKD, Heart Failure, Diabetes Spectrum
The kidney health benefits of SGLT2 inhibitors extend to patient subgroups with chronic kidney disease (CKD) in combo with other conditions.
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific Meeting of the Heart Failure Society of America ...
Krone2h
Heart patients are treated via smartphone
More and more people are suffering from heart failure. However, those affected no longer have to go to hospital all the time: ...